日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  SIRT7: a novel molecular target for personalized cancer treatment?

Ianni, A., Kumari, P., Tarighi, S., Braun, T., & Vaquero, A. (2024). SIRT7: a novel molecular target for personalized cancer treatment? ONCOGENE. doi:10.1038/s41388-024-02976-8.

Item is

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/21.11116/0000-000E-F530-7 版のパーマリンク: https://hdl.handle.net/21.11116/0000-000E-F531-6
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Ianni, Alessandro1, 著者           
Kumari, Poonam1, 著者           
Tarighi, Shahriar1, 著者           
Braun, Thomas1, 著者           
Vaquero, Alejandro, 著者
所属:
1Cardiac Development and Remodeling, Max Planck Institute for Heart and Lung Research, Max Planck Society, ou_2591695              

内容説明

表示:
非表示:
キーワード: -
 要旨: The Sirtuin family of NAD+-dependent enzymes assumes a pivotal role in orchestrating adaptive responses to environmental fluctuations and stress stimuli, operating at both genomic and metabolic levels. Within this family, SIRT7 emerges as a versatile player in tumorigenesis, displaying both pro-tumorigenic and tumor-suppressive functions in a context-dependent manner. While other sirtuins, such as SIRT1 and SIRT6, exhibit a similar dual role in cancer, SIRT7 stands out due to distinctive attributes that sharply distinguish it from other family members. Among these are a unique key role in regulation of nucleolar functions, a close functional relationship with RNA metabolism and processing -exceptional among sirtuins- and a complex multienzymatic nature, which provides a diverse range of molecular targets. This review offers a comprehensive overview of the current understanding of the role of SIRT7 in various malignancies, placing particular emphasis on the intricate molecular mechanisms employed by SIRT7 to either stimulate or counteract tumorigenesis. Additionally, it delves into the unique features of SIRT7, discussing their potential and specific implications in tumor initiation and progression, underscoring the promising avenue of targeting SIRT7 for the development of innovative anti-cancer therapies.

資料詳細

表示:
非表示:
言語:
 日付: 2024-02-212024-02-21
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 識別子(DOI, ISBNなど): ISI: 001168224900002
DOI: 10.1038/s41388-024-02976-8
PMID: 38383727
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: ONCOGENE
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: - 通巻号: - 開始・終了ページ: - 識別子(ISBN, ISSN, DOIなど): ISSN: 0950-9232